Synsorb Biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Synsorb Biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Zabrocki who wrote (12)	2/7/1997 6:32:00 PM
From: Fred J Bealle	of 32

David, the FDA rules are described in www.centerwatch.com/backgrnd.htm. Merger rumors. The interest in Lifetech (lftk on cdn) by Pall Corp may lead to its takeover. Lifetech has granted a 5 year world exclusive license to Pall (a billion dollar sales corp) for $15 million, part of which is to go for equity in Lifetech. To me this is almost like buying out LFTK. The stock in LFTK ipo'd a few months ago; it went last week from $2 to $4 on the Pall news. MY point is that the same could happen to Synsorb. If it grants exclusive licenses to some outfit, worldwide, for all current and future tech, that's the same as selling out. Synsorb's value is only in its licenses....whenever their value is fixed (as approvals mature)....only insiders will know when mergers are being offered. We will know only days or weeks after friends of the insiders have been given their chance to load up on Syb. I like comparison of Lifetech and Synsorb. Both are off the wall; both defy conventional wisdom of pharmaceuticals. fred

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next